| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Total revenue | $30.0M | $0-100.0% | $20.0M | $0 | — | — | — |
| Research and development | $316.9M+43.0% | $221.6M+17.2% | $189.1M+2.5% | $184.5M+58.5% | $116.4M+75.1% | $66.5M+47.7% | $45.0M |
| General and administrative | $52.7M+14.8% | $45.9M+7.1% | $42.9M+12.9% | $38.0M+21.8% | $31.2M+91.3% | $16.3M+95.9% | $8.3M |
| Total operating expenses | $369.6M+38.1% | $267.6M+15.3% | $232.1M+4.3% | $222.5M+50.7% | $147.6M+78.3% | $82.8M+55.2% | $53.4M |
| Loss from operations | -$285.7M-34.1% | -$213.0M-37.4% | -$155.1M+15.7% | -$183.9M-56.0% | -$117.9M-81.4% | -$65.0M-192.2% | -$22.2M |
| Interest and other income, net | $22.0M+11.4% | $19.7M+77.5% | $11.1M+216.9% | $3.5M+326.1% | $823K-31.8% | $1.2M+55.4% | $776K |
| Loss before income taxes | -$263.7M-36.4% | -$193.3M-34.3% | -$143.9M+20.2% | -$180.4M-54.1% | -$117.1M-83.6% | -$63.8M-197.2% | -$21.5M |
| Provision for income taxes | $760K+181.5% | $270K | $0 | $0-100.0% | $131K+100.6% | -$20.5M-8692.1% | $239K |
| Net loss | -$264.5M-36.6% | -$193.6M-34.5% | -$143.9M+20.2% | -$180.4M-53.9% | -$117.2M-171.0% | -$43.2M-99.3% | -$21.7M |
| Net loss per share, basic (in USD per share) | -$3050.00-5.9% | -$2880.00-8.7% | -$2650.00-71328.6% | -$3.71+99.9% | -$2730.00 | — | — |
| Net loss per share, diluted (in USD per share) | -$3050.00-5.9% | -$2880.00-8.7% | -$2650.00-71328.6% | -$3.71+99.9% | -$2730.00 | — | — |
| Weighted-average number of shares outstanding, basic (in shares) | 86.67B+29.1% | 67.12B+23.5% | 54.34B+111688.0% | 48.6M-99.9% | 42.90B | — | — |
| Weighted-average number of shares outstanding, diluted (in shares) | 86.67B+29.1% | 67.12B+23.5% | 54.34B+111688.0% | 48.6M-99.9% | 42.90B | — | — |
| Collaboration revenue | |||||||
| License revenue | |||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.